Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marlise Rachael Luskin, M.D.

Concepts (305)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Marlise Luskin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Marlise Luskin has written about over time.
Hematopoietic Stem Cell Transplantation, 13 publications between 2014 and 2022, average publication date February 2019. fms-Like Tyrosine Kinase 3, 5 publications between 2016 and 2023, average publication date April 2019. Antineoplastic Combined Chemotherapy Protocols, 12 publications between 2011 and 2024, average publication date April 2019. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 4 publications between 2018 and 2022, average publication date April 2019. Hematologic Neoplasms, 9 publications between 2015 and 2024, average publication date September 2019. Aniline Compounds, 2 publications between 2018 and 2021, average publication date October 2019. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 5 publications between 2013 and 2024, average publication date February 2020. Leukemia, Myeloid, Acute, 30 publications between 2014 and 2024, average publication date May 2020. Myelodysplastic Syndromes, 5 publications between 2017 and 2024, average publication date June 2020. Mycoses, 2 publications between 2021 and 2022, average publication date October 2021. Antineoplastic Agents, 7 publications between 2017 and 2024, average publication date December 2021. Myeloproliferative Disorders, 5 publications between 2020 and 2024, average publication date March 2022. Anthracyclines, 2 publications between 2021 and 2023, average publication date June 2022. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 14 publications between 2020 and 2024, average publication date July 2022. Antibodies, Bispecific, 3 publications between 2021 and 2023, average publication date November 2022. Asparaginase, 2 publications between 2022 and 2024, average publication date February 2023.

To see the data from this visualization as text, click here.
Luskin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (305)
Explore
_
Co-Authors (158)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.